University of Pennsylvania Hospital, Abramson Cancer Center — Philadelphia, Pennsylvania

University of Pennsylvania Hospital, Abramson Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

University of Pennsylvania Hospital, Abramson Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Advanced Head and Neck Squamous Cell Carcinoma.

Sponsors: Celldex Therapeutics.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania Hospital, Abramson Cancer Center?

University of Pennsylvania Hospital, Abramson Cancer Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania Hospital, Abramson Cancer Center conducted?

University of Pennsylvania Hospital, Abramson Cancer Center has 1 clinical trials on record. Their work covers Advanced Head and Neck Squamous Cell Carcinoma.

Is University of Pennsylvania Hospital, Abramson Cancer Center accredited by Crixeo Health?

University of Pennsylvania Hospital, Abramson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pennsylvania Hospital, Abramson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.